Mark P. Lappe - 12 Sep 2024 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Sep 2024, 17:12:34 UTC
Prior SEC filing
10 Sep 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kelly D. Deck, as attorney-in-fact for Mark P. Lappe

Key filing fact

Mark P. Lappe filed Form 4 for Inhibrx Biosciences, Inc. (INBX) on 16 Sep 2024.

Key facts

  • This page summarizes Mark P. Lappe's Form 4 filing for Inhibrx Biosciences, Inc. (INBX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Sep 2024, 17:12.

Change

  • Previous filing in this sequence was filed on 10 Sep 2024.
  • Current net transaction value: +$629,117.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBX transaction

Common Stock

Purchase

Transaction value
$405,793
Shares
+26,963
Change %
+4.1%
Price
$15.05
Shares after
692,511
Date
12 Sep 2024
Ownership
By the Lappe Family Trust
Footnotes
F1, F2
INBX transaction

Common Stock

Purchase

Transaction value
$223,324
Shares
+13,037
Change %
+1.9%
Price
$17.13
Shares after
705,548
Date
16 Sep 2024
Ownership
By the Lappe Family Trust
Footnotes
F2, F3
INBX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
165,000
Date
12 Sep 2024
Ownership
By Lappe Descendants' Trust
Footnotes
F4
INBX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
54,865
Date
12 Sep 2024
Ownership
The Mark Paul Lappe Roth IRA
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Footnote F2

These securities are directly owned by the Lappe Family Trust. Mark P. Lappe is a trustee of the Lappe Family Trust and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Lappe Family Trust.

Footnote F3

The shares were purchased in multiple transactions at prices ranging from $16.70 to $17.695, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Footnote F4

These securities are directly owned by a trust, for the benefit of the reporting person's immediate family. Mark P. Lappe, as an immediate family member of the beneficiaries of the trust, may be deemed to indirectly beneficially own the securities owned by the trust.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .